Shares of SMS Pharmaceuticals  climbed 11.8 percent in early trade Monday on getting approval from the US health regulator for one its unit in Andhra Pradesh. "SMS has received approval from the US Food and Drug Administration (USFDA) for manufacturing facility (unit 7) located at Kandivalasa village, Pusapatirega Mandal, Vizianagaram distict, Andhra Pradesh," says the Telangana-based pharma company in its filing. The US health regulator had conducted inspection of this plant in third week of April. At 09:31 hours IST, the scrip of SMS Pharmaceuticals was quoting at Rs 131.50, up Rs 8.50, or 6.91 percent on the BSE.

Taaza Vaartha

Get latest online news, taaza, breaking news updates, political, business, entertainment, movies, music, national, international, state news.

Post A Comment: